Bridger Management LLC Buys 97,000 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Bridger Management LLC increased its stake in Bath & Body Works by 38.9%, acquiring an additional 97,000 shares, bringing its total to 346,615 shares, which represents about 5.2% of its portfolio.
• Bath & Body Works declared a quarterly dividend of $0.20 per share, with a yield of 2.7%, to be paid on September 5th to shareholders of record as of August 22nd.
• The company reported quarterly earnings of $0.37 EPS, matching analysts' expectations, although revenue was down 0.8% year over year at $1.55 billion.

Bridger Management LLC grew its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 38.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 346,615 shares of the company's stock after buying an additional 97,000 shares during the period. Bath & Body Works accounts for about 5.2% of Bridger Management LLC's investment portfolio, making the stock its 7th largest position. Bridger Management LLC owned about 0.16% of Bath & Body Works worth $10,509,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of BBWI. SVB Wealth LLC bought a new stake in shares of Bath & Body Works during the first quarter valued at approximately $35,000. Golden State Wealth Management LLC increased its position in Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after purchasing an additional 642 shares during the last quarter. UMB Bank n.a. increased its position in Bath & Body Works by 65.9% in the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after purchasing an additional 596 shares during the last quarter. Ancora Advisors LLC bought a new stake in Bath & Body Works in the fourth quarter worth $67,000. Finally, GKV Capital Management Co. Inc. bought a new stake in Bath & Body Works in the first quarter worth $69,000. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Price Performance

Bath & Body Works stock traded down $2.38 during trading hours on Friday, reaching $29.49. The stock had a trading volume of 10,016,218 shares, compared to its average volume of 5,680,477. The company has a market cap of $6.08 billion, a price-to-earnings ratio of 8.75, a PEG ratio of 1.01 and a beta of 1.49. The business's 50 day moving average price is $30.73 and its 200-day moving average price is $30.51. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts' consensus estimates of $0.37. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm's revenue was down .8% on a year-over-year basis. During the same period in the previous year, the company posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. The ex-dividend date was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.7%. Bath & Body Works's dividend payout ratio is 23.74%.

Analysts Set New Price Targets

BBWI has been the subject of several recent analyst reports. Barclays lifted their price objective on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research note on Friday, August 29th. UBS Group dropped their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a research note on Friday, August 29th. The Goldman Sachs Group lowered their target price on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Citigroup lowered their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a research note on Tuesday, August 19th. Finally, Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $41.62.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.